These data suggest that increased mitophagy with CRG treatment mitigates NAFLD by inducing Bcl-2 expression, which inhibits apoptosis by lipotoxicity. The gene discussed is BCL2; the disease is metabolic dysfunction-associated steatotic liver disease.